
Ibyra contains Olaparib, a targeted cancer therapy known as a PARP inhibitor. It is used in the treatment of certain BRCA-mutated cancers, including ovarian, breast, prostate, and pancreatic cancers, by preventing cancer cells from repairing their DNA.
| Manufacturer | Cipla |
| Generic Name | Olaparib |
| Strength | 150mg |
| Package size | 60 Tablets |
| Used for | Ovarian, breast, pancreatic, and prostate cancers |

Authentic Medicines

Fast Delivery

Secure Payment

24/7 Support
Purchase Obtain Ibyra (Olaparib 150 mg Tablets) from our reliable international pharmacy, trusted by patients, doctors, clinics, and hospitals worldwide. As a prominent pharmaceutical wholesaler and exporter, we provide genuine generic anticancer medications in bulk to countries including Colombia, Peru, the Philippines, Venezuela, Panama, Ecuador, Namibia, South Africa, Zimbabwe, Bahrain, Cyprus, Egypt, Iran, Iraq, Israel, Jordan, Palestine, Qatar, Saudi Arabia, the UAE, China, Canada, Brazil, Mexico, Russia, Thailand, Malaysia, Singapore, Vietnam, South Korea, Taiwan, Indonesia, the United States, and more.
Disclaimer
All information on this website is for educational purposes only. Medicines should be used only with a doctor’s prescription and supervision. We do not provide medical advice, and product details may change without notice. Always consult a healthcare professional before using any medication.